BioCentury | Sep 15, 2017
Company News

Moderna unveils organizational changes and new candidates

...diseases, immuno-oncology and rare liver diseases. The company will roll its four venture subsidiaries -- Valera...
...Cambridge, Mass. Business: Infectious, Cancer, Endocrine/Metabolic Mary Romeo AZD-8601 mRNA-2416 mRNA-3704 Alexion Pharmaceuticals Inc. AstraZeneca plc CRISPR Therapeutics AG Elpidera LLC Moderna Therapeutics Inc. Valera...
BioCentury | Sep 14, 2017
Company News

Moderna unveils organizational changes and new candidates

...diseases, immuno-oncology and rare liver diseases. The company will roll its four venture subsidiaries -- Valera...
...artery bypass grafting (CABG) surgery. Mary Romeo AZD-8601 mRNA-2416 Alexion Pharmaceuticals Inc. AstraZeneca plc CRISPR Therapeutics AG Elpidera LLC Moderna Therapeutics Inc. Onkaido Therapeutics LLC Valera...
BioCentury | Feb 24, 2017
Product R&D

Two firsts for Zika

...modality - mRNA-based vaccines - could be competitive. The studies, from Moderna Therapeutics Inc. ’s Valera...
...four key features. Figure: Boosting survival Separate papers from Moderna Therapeutics Inc. 's vaccine spinout Valera...
...vaccines that could help treat Zika virus. In a Cell paper published last week, the Valera...
BioCentury | Feb 23, 2017
Distillery Therapeutics

Infectious disease

...J. et al. Cell Rep .; published online Feb. 17, 2017 doi:10.1016/j.cell.2017.02.017 CONTACT: Giuseppe Ciaramella, Valera...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, Merck deal

...deal granted Merck rights to five mRNA-based treatments and vaccines against four undisclosed viruses. Moderna’s Valera...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, Valera, Bill & Melinda Gates Foundation infectious news

...Moderna’s Valera LLC company will receive up to $20 million in grant funding from the foundation...
...from the foundation to develop a combination of mRNA-based antibody therapeutics to prevent HIV infection. Valera...
...Valera in Jan. 2015 (see BioCentury, Feb. 2, 2015). Moderna Therapeutics Inc. , Cambridge, Mass. Valera...
BioCentury | Jan 12, 2016
Company News

Moderna expands Merck, AZ partnerships

...vaccine candidate mRNA 1566 and related candidates. Merck will lead development and commercialization, while Moderna's Valera...
BioCentury | Oct 16, 2015
Company News

Moderna CSO Bolen resigns

...President Stephen Hodge, CMO Tal Zaks and the CSOs of Moderna subsidiaries Elpidera LLC , Valera...
BioCentury | May 13, 2015
Company News

Moderna creates rare disease subsidiary Elpidera

...subsidiary Moderna has created under its decentralized drug development business strategy. In January, Moderna launched Valera...
BioCentury | Feb 23, 2015
Company News

Moderna Therapeutics, Valera, Institut Pasteur deal

...Moderna’s Valera LLC company and Institut Pasteur partnered to discover and develop drugs and vaccines to...
...discover and develop drugs and vaccines to treat infectious diseases using Moderna’s mRNA therapeutics platform. Valera...
...Moderna launched Valera last month (see BioCentury, Feb. 2). Moderna Therapeutics Inc. , Cambridge, Mass. Valera...
Items per page:
1 - 10 of 87
BioCentury | Sep 15, 2017
Company News

Moderna unveils organizational changes and new candidates

...diseases, immuno-oncology and rare liver diseases. The company will roll its four venture subsidiaries -- Valera...
...Cambridge, Mass. Business: Infectious, Cancer, Endocrine/Metabolic Mary Romeo AZD-8601 mRNA-2416 mRNA-3704 Alexion Pharmaceuticals Inc. AstraZeneca plc CRISPR Therapeutics AG Elpidera LLC Moderna Therapeutics Inc. Valera...
BioCentury | Sep 14, 2017
Company News

Moderna unveils organizational changes and new candidates

...diseases, immuno-oncology and rare liver diseases. The company will roll its four venture subsidiaries -- Valera...
...artery bypass grafting (CABG) surgery. Mary Romeo AZD-8601 mRNA-2416 Alexion Pharmaceuticals Inc. AstraZeneca plc CRISPR Therapeutics AG Elpidera LLC Moderna Therapeutics Inc. Onkaido Therapeutics LLC Valera...
BioCentury | Feb 24, 2017
Product R&D

Two firsts for Zika

...modality - mRNA-based vaccines - could be competitive. The studies, from Moderna Therapeutics Inc. ’s Valera...
...four key features. Figure: Boosting survival Separate papers from Moderna Therapeutics Inc. 's vaccine spinout Valera...
...vaccines that could help treat Zika virus. In a Cell paper published last week, the Valera...
BioCentury | Feb 23, 2017
Distillery Therapeutics

Infectious disease

...J. et al. Cell Rep .; published online Feb. 17, 2017 doi:10.1016/j.cell.2017.02.017 CONTACT: Giuseppe Ciaramella, Valera...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, Merck deal

...deal granted Merck rights to five mRNA-based treatments and vaccines against four undisclosed viruses. Moderna’s Valera...
BioCentury | Jan 18, 2016
Company News

Moderna Therapeutics, Valera, Bill & Melinda Gates Foundation infectious news

...Moderna’s Valera LLC company will receive up to $20 million in grant funding from the foundation...
...from the foundation to develop a combination of mRNA-based antibody therapeutics to prevent HIV infection. Valera...
...Valera in Jan. 2015 (see BioCentury, Feb. 2, 2015). Moderna Therapeutics Inc. , Cambridge, Mass. Valera...
BioCentury | Jan 12, 2016
Company News

Moderna expands Merck, AZ partnerships

...vaccine candidate mRNA 1566 and related candidates. Merck will lead development and commercialization, while Moderna's Valera...
BioCentury | Oct 16, 2015
Company News

Moderna CSO Bolen resigns

...President Stephen Hodge, CMO Tal Zaks and the CSOs of Moderna subsidiaries Elpidera LLC , Valera...
BioCentury | May 13, 2015
Company News

Moderna creates rare disease subsidiary Elpidera

...subsidiary Moderna has created under its decentralized drug development business strategy. In January, Moderna launched Valera...
BioCentury | Feb 23, 2015
Company News

Moderna Therapeutics, Valera, Institut Pasteur deal

...Moderna’s Valera LLC company and Institut Pasteur partnered to discover and develop drugs and vaccines to...
...discover and develop drugs and vaccines to treat infectious diseases using Moderna’s mRNA therapeutics platform. Valera...
...Moderna launched Valera last month (see BioCentury, Feb. 2). Moderna Therapeutics Inc. , Cambridge, Mass. Valera...
Items per page:
1 - 10 of 87